AG
KLRS
Artal Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,597,167
| Closed | -$4.77M | – | 103 |
|
|
2024
Q2 | $4.77M | Hold |
6,597,167
| – | – | 0.12% | 57 |
|
|
2024
Q1 | $4.98M | Hold |
6,597,167
| – | – | 0.13% | 61 |
|
|
2023
Q4 | $4.49M | Hold |
6,597,167
| – | – | 0.15% | 53 |
|
|
2023
Q3 | $14.2M | Hold |
6,597,167
| – | – | 0.61% | 23 |
|
|
2023
Q2 | $22.4M | Buy |
6,597,167
+1,020,000
| +18% | +$3.47M | 0.7% | 21 |
|
|
2023
Q1 | $22M | Hold |
5,577,167
| – | – | 1.31% | 20 |
|
|
2022
Q4 | $28.6M | Hold |
5,577,167
| – | – | 1.6% | 18 |
|
|
2022
Q3 | $44M | Buy |
5,577,167
+3,253,796
| +140% | +$25.7M | 1.88% | 16 |
|
|
2022
Q2 | $9.06M | Hold |
2,323,371
| – | – | 0.48% | 39 |
|
|
2022
Q1 | $15.7M | Hold |
2,323,371
| – | – | 0.66% | 35 |
|
|
2021
Q4 | $30.1M | Hold |
2,323,371
| – | – | 0.82% | 28 |
|
|
2021
Q3 | $58.2M | Hold |
2,323,371
| – | – | 1.3% | 19 |
|
|
2021
Q2 | $45.9M | Hold |
2,323,371
| – | – | 0.93% | 19 |
|
|
2021
Q1 | $54.4M | Hold |
2,323,371
| – | – | 0.96% | 18 |
|
|
2020
Q4 | $89.3M | Hold |
2,323,371
| – | – | 1.92% | 12 |
|
|
2020
Q3 | $63.9M | Buy |
+2,323,371
| New | +$63.9M | 1.55% | 12 |
|